Insulin resistance (IR), characterized by diminished sensitivity or responsiveness to insulin, is implicated in the etiology of numerous disorders, including non-alcoholic fatty liver disease (NAFLD), diabetes mellitus (DM), cardiovascular disease (CVD), and cognitive impairment [8–10]. Here, INS is linked to metabolic dysfunction-associated steatotic liver disease.